Check out our other projects here 

 

Cytotrait secures £3M seed funding to address global food security and sustainable agriculture

Cytotrait, a biotechnology spinout from The University of Manchester commercialised with support from the University of Manchester Innovation Factory, focused on the development of novel traits for food and agriculture, today announced the close of its £3M seed funding round.

Double Success for University of Manchester Spinouts at the Bionow Awards

Two University of Manchester spinouts have been recognised with major awards at this year’s Bionow Awards, with a further University project shortlisted in the Rising Star category.  The awards celebrate excellence across the UK life sciences sector and recognise organisations and individuals driving innovation in healthcare, biotechnology and pharmaceuticals.

James Winterburn Appointed Expert in Residence at the University of Manchester Innovation Factory

The Innovation Factory has appointed Prof. James Winterburn as Green-tech Expert in Residence, marking the next chapter in a long-standing relationship between academic research, commercialisation and industrial impact.

University of Manchester Spinout Complement Therapeutics Secures UK Approval for First-in-human Gene Therapy Trial

Complement Therapeutics, a University of Manchester spinout, has received UK Clinical Trial Authorisation to begin a Phase I/II clinical trial of its lead gene therapy programme, CTx001, for Geographic Atrophy secondary to age-related macular degeneration.